What is the PCT?

The Patent Cooperation Treaty (PCT) is an international treaty administered by the World Intellectual Property Organization (WIPO). It allows inventors and companies to seek patent protection in over 150 countries through a single, unified application. Rather than filing separate patent applications in every country you wish to protect your invention—each with its own fees, deadlines, and requirements—the PCT provides a streamlined pathway that preserves your options worldwide while deferring significant costs and decisions.

Filing a PCT application does not result in an “international patent.” No such thing exists. What the PCT provides is a coordinated procedure: one filing, one search, and a period of time — up to 30 months from your earliest filing date — to decide which countries you ultimately wish to pursue before committing to the costs of national phase examination in each.

Why Do Inventors and Companies Use the PCT?

The PCT is widely used because it solves a timing problem that is fundamental to patent strategy. Patent protection is territorial: a US patent protects your invention only in the United States. If you want protection in Europe, Japan, China, or elsewhere, you must file in each of those places. The challenge is that most patent systems require foreign filings within 12 months of your first application. For a startup or individual inventor, that timeline can be extremely difficult to meet across many countries simultaneously.

The PCT extends that window to 30 months, giving you nearly two and a half years from your original filing date to:

• Assess the commercial potential of your invention in different markets

• Review the International Search Report for early patentability signals

• Refine or narrow your claims before entering national examination

• Raise funding or secure partnerships that may inform which markets matter

• Prepare translations and engage local patent counsel in each target country

For biotechnology and life sciences companies in particular, the PCT is nearly universal practice because the path from invention to commercialization is long, and the ability to delay country-by-country commitment by 18 additional months is highly valuable.

How the PCT Process Works.

The PCT process unfolds in two distinct phases: the international phase and the national phase. Understanding both is essential to making informed decisions about your IP strategy.

The International Phase.

The international phase begins when you file your PCT application with a Receiving Office — typically the patent office of your home country (for US applicants, the USPTO) or directly with WIPO. The PCT application must be filed within 12 months of your earliest priority filing (e.g., a US provisional or nonprovisional application).

During the international phase, an International Searching Authority (ISA) — most commonly the USPTO, the European Patent Office (EPO), or the Japan Patent Office (JPO) — conducts a search of the global patent and scientific literature and issues two documents:

• International Search Report (ISR): A list of prior art documents the ISA considers relevant to the novelty and inventive step of your claims.

• Written Opinion (WO): The ISA’s preliminary, non-binding assessment of whether your claims appear to meet the key patentability requirements of novelty, inventive step, and industrial applicability.

These documents are typically issued around 16–18 months from your priority date and are published along with your application at the 18-month mark. They are not legally binding, meaning no national office is required to reach the same conclusions, but they are an important strategic signal.
The National Phase

The national phase begins when you elect to pursue patent protection in specific countries, which must generally occur by 30 months from your earliest priority date (31 months in some jurisdictions). At this point, the PCT framework steps back and each country’s own patent law takes over.

In each elected country, you will typically need to:

• Pay the national filing and examination fees

• File a translation of the application if the national office requires a language other than the one your PCT application was filed in

• Engage local patent counsel to handle prosecution

• Respond to Office Actions issued by the national examiner

The national phase examination in each country is entirely independent. Examiners are not bound by the ISR or Written Opinion, and the standards for patentability differ by jurisdiction. A claim that is allowed in the US may face additional hurdles at the EPO, and vice versa.

PCT Timeline at a Glance.

The table below summarizes the key milestones in a typical PCT prosecution from the initial priority filing through national phase entry.

* Some countries require national phase entry by 31 months. Your attorney will confirm the deadlines for each jurisdiction you elect.

PCT vs. Direct National Filing: Which Is Right for You?

The PCT is not the only route to international patent protection. Under the Paris Convention, you may also file directly in each country within 12 months of your priority date, claiming the same priority date. The right choice depends on your circumstances.

In most cases where international protection is a serious consideration, the PCT route is preferable because of the extended decision window and the early patentability signal from the ISR. However, if you have a very limited target country list and a strong commercial reason to file quickly — for example, if you need a granted patent in a specific market within a defined timeframe — direct filing may be more appropriate. 

Does the PCT Application Grant Me a Patent?

No. This is the most common misconception about the PCT. The PCT application itself is not a patent and does not grant any patent rights. It is a procedural vehicle, an application framework that preserves your right to seek patents in over 150 countries through a single, coordinated process.

Patent rights are granted only by national (or regional) patent offices, after independent examination under the laws of each jurisdiction. Until a national office examines your application, issues any necessary Office Actions, and ultimately allows your claims, you do not have an enforceable patent in that country.

What the PCT does give you is:

• A unified international filing date recognized by all PCT member states

• An extended window — up to 30 months from your priority date — to make national phase entry decisions

• An International Search Report that provides early intelligence on the prior art landscape

• The option of an international preliminary examination to strengthen your position before national phase

• A single application document that serves as the basis for all national phase filings, reducing duplication of effort

Regional Patent Systems Within the PCT Framework.

In addition to filing in individual countries during the national phase, the PCT also connects to several regional patent systems that allow a single application to be examined and granted across multiple member states:

European Patent Office (EPO).

A PCT application entering the European regional phase is examined by the EPO. A granted European patent can then be “validated” in individual European countries by paying national validation fees and, in some cases, filing translations. Validation in the key European markets — Germany, France, the UK, and others — effectively gives you national patent rights in each validated country from a single EP grant.

Unitary Patent (EU).

Since June 2023, applicants who receive a European patent from the EPO can opt for a “Unitary Patent” that automatically provides protection in participating EU member states without separate national validation. This significantly reduces the post-grant cost of maintaining European patent coverage.

Other Regional Offices.

Other regional patent systems accessible through the PCT include the African Regional Intellectual Property Organization (ARIPO), the African Intellectual Property Organization (OAPI), the Eurasian Patent Organization (EAPO), and the Gulf Cooperation Council (GCC) Patent Office. The right combination of national and regional filings depends on your geographic markets and budget.

Understanding PCT Costs.

The PCT is often described as “cheaper upfront” than direct filing, which is true — but it is important to understand that the PCT does not reduce the total cost of obtaining international patent protection. It defers and spreads those costs over a longer period. The major cost stages are:

Planning ahead is essential: national phase entry decisions involve significant financial commitments, and the deadlines are firm.

Key Takeaways.

This article is intended as a general educational resource for clients and does not constitute legal advice specific to your application or situation. Patent laws and PCT procedures change over time. Please consult your attorney/agent for guidance tailored to your invention and business objectives.